Obstetrics, Gynecology and Women's Health - Oncology

41 Active
119 Finished

41 results

Filter

Active

A Randomized, Open-label, Phase 3 Study of Sacituzumab GovitecanVersus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Erickson, B. K. (PI)
GILEAD SCIENCES, INC.
8/5/24 → 8/4/35
Project: Research project
GMP manufacturing of cytokine armored CAR-NK cells for the treatment of advanced epithelial ovarian cancer
Moriarity, B. S. (PI) & Geller, M. A. (Co-Principal Investigator)
MN OVARIAN CANCER ALLIANCE
8/1/24 → 7/31/25
Project: Research project
A Phase 2 Pan-tumor, Open-label Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects with Recurrent or Metastatic Solid Tumors (IDeate-5)
Teoh, D. G. (PI)
DAIICHI SANKYO, INC.
7/10/24 → 7/9/35
Project: Research project
Trapping Inhibitory Signals in Synergy with Cytokine Signaling to Maximize NK Cell Immunotherapy in Ovarian Cancer
Geller, M. A. (PI) & Vogel, R. (CoI)
US DEPT OF DEFENSE ARMY
7/1/24 → 6/30/28
Project: Research project
A Two-Arm Randomized, Double-Blind, Placebo-Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive, PD-L1-positive...
Teoh, D. G. (PI)
NYKODE THERAPEUTICS ASA
6/10/24 → 6/9/35
Project: Research project
UW Support Services Agreement (UWMSN-2024-2662-ASSA3)
Argenta, P. A. (PI)
UNIVERSITY OF WISCONSIN-MADISON, CENTERS FOR DISEASE CONTROL & PREVENTION
4/1/24 → 9/29/24
Project: Research project
Cancer Center Support Grant
Yee, D. (PI), Antonarakis, E. (CoI), Beckman, K. B. (CoI), Betts, B. (CoI), Blaes, A. H. (CoI), Eaton, A. (CoI), Ellis, K. M. (CoI), Felices, M. (CoI), Geller, M. A. (CoI), Ghebre, R. G. (CoI), Griffin, T. J. (CoI), Hallstrom, T. C. (CoI), Harki, D. A. (CoI), Hatsukami, D. K. (CoI), Hirsch, B. A. (CoI), Huang, R. S. S. (CoI), Johnson, S. (CoI), Juckett, M. B. (CoI), Lange, C. A. (CoI), Le, C. T. (CoI), Luo, X. (CoI), McKenna, D. H. (CoI), Miller, J. S. (CoI), Moriarity, B. S. (CoI), Muretta, J. M. (CoI), Murray, T. (CoI), Nelson, H. H. (CoI), Ondrey, F. G. (CoI), Patel, M. R. (CoI), Pennell, C. A. (CoI), Petersen, A. J. (CoI), Peterson, L. A. (CoI), Poynter, J. (CoI), Pratt, R. J. (CoI), Sarver, A. L. (CoI), Schendzielos, D. L. (CoI), Schilz, A. (CoI), Schwertfeger, K. (CoI), Seelig, D. (CoI), Shimizu, Y. (CoI), Stepanov, I. (CoI), Temiz, N. A. (CoI), Ventz, S. (CoI), Villalta, P. W. (CoI), Vogel, R. (CoI), Wagner, J. E. (CoI), Wang, J. (CoI), Webber, B. R. (CoI), Weigel, B. J. (CoI), Yamamoto, M. (CoI) & Zhang, L. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/24 → 1/31/29
Project: Research project
Phase 1/2 Study of REGN5668 (MUC16 X CD28, a Costimulatory Bispecific) Administered in Combination with Cemiplimab or REGN4018 (MUC16 X CD3)
Geller, M. A. (PI)
REGENERON PHARMACEUTICALS, INC.
1/17/24 → 1/17/34
Project: Research project
Development and Pilot Testing of a mLearning Intervention to Address Sexual Health Needs of Gynecologic Cancer Survivors
Girard, A. (PI), Geller, M. A. (CoI), Pratt, R. J. (CoI), Rider, G. N. (CoI) & Vogel, R. (CoI)
AMERICAN CANCER SOCIETY, INC
1/1/24 → 12/31/27
Project: Research project
Precision medicine for ARID1A-mutated ovarian cancer
Bazzaro, M. (PI) & Petersen, A. J. (CoI)
MN OVARIAN CANCER ALLIANCE
10/1/23 → 9/30/24
Project: Research project
Ovarian Cancer Precision Medicine Initiative (OCPMI)
Winterhoff, B. J. (PI), Henzler, C. (CoI) & Nelson, A. C. (CoI)
ADELSON MEDICAL RESEARCH FOUNDATION
10/1/23 → 9/30/24
Project: Research project
Increasing access to cancer trials in Minnesota (InACT-MN)
Erickson, B. K. (PI), Geller, M. A. (CoI), Greeno, E. W. (CoI), Kratzke, R. A. (CoI), Ondrey, F. G. (CoI), Teoh, D. G. (CoI) & Yee, D. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
9/18/23 → 8/31/28
Project: Research project
Northwestern Cancer Prevention Consortium -- Surgical Window of Opportunity Study of Megestrol Acetate Compared with Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia - Fixed Price
Erickson, B. K. (PI)
NORTHWESTERN UNIVERSITY, NIH NATIONAL CANCER INSTITUTE (NCI)
8/1/23 → 7/31/25
Project: Research project
Do Cytomegalovirus and Epstein-Barr virus infections exacerbate symptoms of cognitive decline following chemotherapy for ovarian cancer?
Vogel, R. (PI) & Geller, M. A. (CoI)
U.S. DEPARTMENT OF DEFENSE
7/15/23 → 7/14/25
Project: Research project
Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life
Vogel, R. (PI), Blaes, A. H. (CoI) & Teoh, D. G. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
2/3/23 → 1/31/27
Project: Research project
APOBEC Mutagenesis in Breast Cancer
Harki, D. A. (PI), Walters, M. A. (CoI) & Vogel, R. (Other Role)
UT HEALTH SCIENCE CENTER SAN ANTONIO, NATIONAL INSTITUTES OF HEALTH (NIH)
8/1/22 → 7/31/25
Project: Research project
Application of engineered tumor infiltrating lymphocytes (TIL) in pediatric osteosarcoma
Webber, B. R. (PI), Largaespada, D. A. (CoI), Moriarity, B. S. (CoI), Starr, T. (CoI) & Weigel, B. J. (CoI)
V FOUNDATION FOR CANCER RESEARCH
7/15/22 → 7/15/25
Project: Research project
A Randomized Controlled Trial of Robotic versus Open Radical Hysterectomy for Cervical Cancer(ROCC trial)
Rivard, C. (PI)
THE GOG FOUNDATION, INC
6/21/22 → 12/31/26
Project: Research project
A PHASE 1, FIRST IN HUMAN, DOSE-ESCALATION STUDY OF TORL-1-23 IN PARTICIPANTS WITHADVANCED CANCER
Winterhoff, B. J. (PI)
TORL BIOTHERAPEUTICS, LLC
4/1/22 → 1/1/26
Project: Research project
UNC-45A uniquely contributes to AD pathology
Bazzaro, M. (PI)
ALZHEIMER'S ASSOCIATION
2/1/22 → 1/31/25
Project: Research project
A Phase I Study of HCW9218, a Bifunctional TGF-? Antagonist/IL-15 Protein Complex, in Select Advanced Solid Tumors After Failing at Least Two Prior Therapies
Geller, M. A. (PI)
HCW BIOLOGICS, INC
1/21/22 → 1/31/26
Project: Research project
A Phase 3 Randomized, Open-label, Active-comparator Controlled ClinicalStudy of Pembrolizumab versus Platinum Doublet Chemotherapy in Participants WithMismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in theFirst-line Settin
Geller, M. A. (PI)
THE GOG FOUNDATION, INC, MERCK, SHARP & DOHME LLC
11/2/21 → 11/30/26
Project: Research project
Intra-tumoral activation of antiviral CD8 T cells for tumor immunotherapy
Masopust, D. (PI), Geller, M. A. (CoI) & Vezys, V. (CoI)
V FOUNDATION FOR CANCER RESEARCH
11/1/21 → 11/1/24
Project: Research project
NRG-GY023: A RANDOMIZED PHASE II TRIAL OF TRIPLET THERAPY (A PD-L1 INHIBITOR DURVALUMAB(MEDI4736) IN COMBINATION WITH OLAPARIB AND CEDIRANIB) COMPARED TO OLAPARIB ANDCEDIRANIB OR DURVALUMAB (MEDI4736) AND CEDIRANIB OR STANDARD OF CARE CHEMOTHERAPYIN W
Teoh, D. G. (PI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
10/29/21 → 2/28/25
Project: Research project
Increasing HPV vaccination coverage among adolescent and young adult (AYA) cancer survivors: A multilevel intervention
Teoh, D. G. (PI), Melton-Meaux, G. B. (CoI), Sadak, K. T. (CoI) & Vogel, R. (CoI)
U.S. DEPARTMENT OF DEFENSE
8/15/21 → 8/14/25
Project: Research project
A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection
Skubitz, A. P. (PI), Boylan, K. L. (CoI), Geller, M. A. (CoI) & Petersen, A. J. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
8/5/21 → 7/31/26
Project: Research project
Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment ofPatients receiving Neoadjuvant Chemotherapy with Advanced-Stage Ovarian, Fallopian Tube or PrimaryPeritoneal Cancer who are Folate Receptor positive
Erickson, B. K. (PI)
THE UNIVERSITY OF ALABAMA, IMMUNOGEN, INC
6/28/21 → 6/30/26
Project: Research project
A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent orPersistent Endometrial Cancer
Erickson, B. K. (PI)
ALLIANCE FOUNDATION TRIALS, LLC
5/19/21 → 5/31/26
Project: Research project
Phase 1 First-in-Human Study of Leukocyte Immunoglobulin-Like Receptor B2 (LILRB2) Inhibitor Monoclonal Antibody (mAb) JTX-8064, as Monotherapy and in Combination with a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, in Adult Subjectswith Advanced
Teoh, D. G. (PI)
JOUNCE THERAPEUTICS, INC
5/1/21 → 4/30/26
Project: Research project
NK cells, their receptors, and cancer therapy
Miller, J. S. (PI), Bachanova, V. (CoI), Basu, S. (CoI), Brunstein, C. G. (CoI), Cichocki, F. M. (CoI), Felices, M. (CoI), Geller, M. A. (CoI), Grzywacz, B. J. (CoI), Le, C. T. (CoI), Luo, X. (CoI), Starr, T. (CoI), Walcheck, B. (CoI), Warlick, E. D. (CoI) & Weisdorf, D. J. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
4/9/21 → 3/31/26
Project: Research project
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
Walcheck, B. (PI), Geller, M. A. (CoI), Miller, J. S. (CoI), Moriarity, B. S. (CoI), Rendahl, A. (CoI), Starr, T. (CoI) & Wu, J. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
4/1/21 → 3/31/26
Project: Research project
A NON-RANDOMIZED PROSPECTIVE CLINICAL TRIAL COMPARING THE NON-INFERIORITY OFSALPINGECTOMY TO SALPINGO-OOPHORECTOMY TO REDUCE THE RISK OF OVARIAN CANCERAMONG BRCA1 CARRIERS [SOROCk]
Erickson, B. K. (PI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
3/31/21 → 2/28/25
Project: Research project
A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with SolidTumors Likely to Express NaPi2b
Winterhoff, B. J. (PI)
MERSANA THERAPEUTICS, INC
4/23/20 → 4/30/25
Project: Research project
The role of cytomegalovirus and inflammation on patient symptoms and outcomes in ovarian cancer
Vogel, R. (PI) & Geller, M. A. (CoI)
US DEPT OF DEFENSE ARMY
7/1/19 → 6/30/25
Project: Research project
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Teoh, D. G. (PI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
3/15/19 → 2/28/25
Project: Research project
Phase II Study of Pembrolizumab in the Immunoreactive Ovarian Cancer Subtype
Winterhoff, B. J. (PI)
UNIVERSITY OF CALIFORNIA, LOS ANGEL, MERCK
3/6/19 → 3/30/26
Project: Research project
NRG Oncology Fixed Price Subaward Master Agreement
Geller, M. A. (PI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
3/1/19 → 2/28/25
Project: Research project
A Randomized, Double-Blind, Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Teoh, D. G. (PI)
TESARO, INC.
9/1/18 → 6/26/26
Project: Research project
A phase III multicenter randomized study of atezolizumab
Geller, M. A. (PI)
GENENTECH, INC.
6/1/17 → 3/31/25
Project: Research project
A Randomized Phase II/III study of the combination of Ce
Geller, M. A. (PI)
NRG ONCOLOGY FOUNDATION, INC.
1/1/17 → 2/28/25
Project: Research project
A Phase III study comparing single-agent olaparib or the
Geller, M. A. (PI)
NRG ONCOLOGY FOUNDATION, INC.
10/1/16 → 2/28/25
Project: Research project